Loading company…
Riskpilot
← Back to search
Sign in
Get full access
LOGISENSE AS
AS
Active
Org 924681209
Storebotn 26, 5309 Kleppestø
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 2020
3 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 18,1M
+34% vs 2023
EBITDA margin
40.2%
+130% vs 2023
Equity ratio
3.9%
Financial strength
Net profit 2024
NOK 5,6M
+136% vs 2023
EBITDA — year on year
NOK millions
0M
2M
4M
7M
9M
3M
2020
3M
0%
2021
2M
-33%
2022
3M
+50%
2023
7M
+133%
2024
Key figures
Annual report 2024
Revenue
NOK 18,1M
+34%
EBITDA
NOK 7,3M
+130%
Net profit
NOK 5,6M
+136%
Total assets
NOK 12,2M
+136%
Equity
NOK 480K
-79%
Employees
3
—
Company information
Legal name
LOGISENSE AS
Org number
924681209
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
28. februar 2020
Share capital
NOK 30 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Konsulent, og handel med utstyr for dysleksi.
Contact
Address
Storebotn 26, 5309 Kleppestø
Phone
+4722120086
Email
post@logisense.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in Askøy
All Norway companies
Revenue
NOK millions
0M
5M
10M
16M
21M
6M
2020
10M
2021
11M
2022
13M
2023
18M
2024
EBITDA
NOK millions
0M
2M
4M
6M
8M
3M
2020
3M
2021
2M
2022
3M
2023
7M
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
5 871
9 689
10 914
13 445
18 072
Staff expenses
−0
−642
−2 806
−2 529
−2 404
EBITDA
2 512
2 612
1 715
3 166
7 271
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
2 512
2 612
1 715
3 166
7 271
Net financials
22
3
−54
−95
−27
Profit before tax
2 534
2 615
1 660
3 071
7 244
Tax
557
575
365
675
1 595
Net profit
1 976
2 039
1 295
2 396
5 649
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
3 371
4 873
3 137
5 166
12 195
Equity
2 001
840
−65
2 331
480
Long-term debt
0
0
0
0
0
Short-term debt
1 371
4 033
3 201
2 835
11 716
Total debt
1 371
4 033
3 201
2 835
11 716
Financial ratios
5-year trend
EBITDA margin
40.2%
This company
15.8%
Market median
+154% vs market
2020
2024
Equity ratio
3.9%
This company
38.2%
Market median
-90% vs market
2020
2024
Return on equity
1177.6%
This company
18.4%
Market median
+6300% vs market
2020
2024
Net profit margin
31.3%
This company
8.1%
Market median
+286% vs market
2020
2024
Asset turnover
1.48×
This company
1.12×
Market median
+32% vs market
2020
2024
Debt / equity
24.42×
This company
0.62×
Market median
-3839% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Age
Other directorships
RM
Ronny Mjelva
Chairman
2020
—
—
ML
Mona Lisa Flaen Aakre
Board of Directors
2020
—
—
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Mjelva Invest As
Company
50.0%
50.0%
2023
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Mjelva Invest As
LOGISENSE AS
(this company)
Board network connections
Board members of LOGISENSE AS also hold positions in
0
other companies.
Person
Role here
Other companies
Ronny Mjelva
Chairman
0 companies
Mona Lisa Flaen Aakre
Board of Directors
0 companies